Fluid Optimization in Liver Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Germano De Cosmo, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier:
NCT01627808
First received: June 22, 2012
Last updated: June 25, 2012
Last verified: June 2012

June 22, 2012
June 25, 2012
September 2011
February 2012   (final data collection date for primary outcome measure)
Stroke volume variation [ Time Frame: at time of surgery ] [ Designated as safety issue: Yes ]
Evaluation of changes in Stroke Volume Variation from Vigileo/FloTrac system during liver resection.
Same as current
Complete list of historical versions of study NCT01627808 on ClinicalTrials.gov Archive Site
Stroke volume variation [ Time Frame: at the end of surgery ] [ Designated as safety issue: Yes ]
Evaluation of changes in Stroke Volume Variation at the end of liver resection, during fluid optimization.
Same as current
Not Provided
Not Provided
 
Fluid Optimization in Liver Surgery
Study on Fluid Optimization in Liver Surgery Trough Vigileo/FloTac System Associated to Traditional Monitoring.

The purpose of this study is to analyze hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.

To reduce bleeding, hepatectomies are performed with low central pressure (CVP) combined with extrahepatic control flow.

This management can lead hemodynamic instability and reduction in oxygen delivery so an advanced monitoring should be used.

This study analyzes hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

In this study were enrolled patients scheduled for elective major hepatic surgery.

Cancer of Liver
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
17
May 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ASA I-III

Exclusion Criteria:

  • Cirrhosis
  • systolic ventricular contractility or diastolic relaxation alterations
  • ischemic or valvular diseases
  • absence of sinusal rhythm
  • impaired renal function
Both
30 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
NCT01627808
656/11
No
Germano De Cosmo, Catholic University of the Sacred Heart
Catholic University of the Sacred Heart
Not Provided
Principal Investigator: Germano De Cosmo, PhD Catholic University of Sacred Heart
Catholic University of the Sacred Heart
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP